Synthesis of some pyrazolone derivatives from ciprofloxacin and study of their cytotoxicity
Keywords:Ciprofloxacin, Cytotoxicity, Pyrazolone
Three pyrazolone derivativeswith pyrazole ring extensionwere synthesized from ciprofloxacin by treating the parent compound with hydrazine derivatives. All the products have been characterized by IR and 1H-NMR spectral analysis. These derivatives showed potential cytotoxicity against brine shrimp nauplii than the ciprofloxacin.
Bekhit AA, Fahmy HT. Design and synthesis of some substituted 1H-pyrazolyl-oxazolidines or 1H-pyrazolyl-thiazolidines as anti-inflammatory-antimicrobial agents. Arch Pharm (Weinheim). 2003; 336: 111-18.
Gürsoy A, Demirayak S, Capan G, Erol K, Vural K. Synthesis and preliminary evaluation of new 5-pyrazolinone derivatives as analgesic agents. Eur J Med Chem. 2000; 35: 359-64.
Islam MR, Khayer K, Ahmad MM. Synthesis of 3-methylpyrazoline-5-one and its 3,3-dimethyl-5,5-ethene-bis-2-pyrazoline-4,4-dione, substituted cyclic tri-azothione and N-acetylated derivatives. J Bangladesh Chem Soc. 2001; 14: 33.
Islam MR, Mohsin M. Synthesis of isatin, 5-chloroisatin and their ?2 -1,3,4-oxadiazoline derivatives for comparative cytotoxicity study on brine shrimp. Bangladesh J Pharmacol. 2007; 2: 7-12.
Manna F, Chimenti F, Bolasco A, Cenicola ML, DAmico M, Parrillo C, Rossi F, Marmo E. Anti-inflammatory, analgesic and antipyretic N-acetyl-?2-pyrazolines and dihydrothienocoumarines. Eur J Med Chem. 1992; 27: 633-39.
Solis PN, Wright CW, Anderson MM, Gupta MP, Phillipson JD. A microwell cytotoxicity assay using Artemia salina (brine shrimp). Planta Med. 1993; 59: 250-52.
Regan J, Capolino A, Cirillo PF, Gilmore T, Graham AG, Hickey E, Kroe RR, Madwed J, Moriak M, Nelson R, Pargellis CA, Swinamer A, Torcellini C, Tsang M, Moss N. Structure activity relationships of the p38alpha MAP kinase inhibitor 1-(5-tert-butyl-2-p-tolyl-2H-pyrazol-3yl)-3-[4-(2-morpholin-4-yl-ethoxy) maphthalen-1-yl]urea (BIRB 796). J Med Chem. 2003; 46: 4676-86.
Satyanarayana K, Rao MNA. Synthesis of 4-[5-(substituted aryl)-4,5-dihydro-1H-pyrazol-3-yl]-3-phenyl-sydnones as anti-inflammatory, antiarthritic and analgesic agents. Eur J Med Chem. 1995; 30: 641-45.
How to Cite
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).